General Information
Version
02/16/2024
Revision date
2024-02-16
Product name
Cefoxitin for Injection, USP
Product name
Cefoxitin for Injection, USP
Identification on the label/Trade name
Cefoxitin for Injection, USP | Manufacturer Fresenius Kabi USA LLC
CAS No.
33564-30-6
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H317, H334, H362
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
Signal word
DANGER. GHS Class Respiratory sensitisation. category 1. Skin Sensitization. category 1. Reproductive toxicity. Effects on or via lactation.
Hazard statements
May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause an allergic skin reaction. May cause harm to breast-fed children.
Precautionary statements
Obtain special instructions before use. Do not breathe dust/fume/gas/mist/vapours/spray. Avoid breathing dust/fume/gas/mist/vapours/spray. Avoid contact during pregnancy and while nursing. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves/protective clothing/eye protection/face protection. In case of inadequate ventilation wear respiratory protection. IF ON SKIN: Wash with plenty of water. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. IF exposed or concerned: Get medical advice/attention. Specific treatment (see ... on this label). If skin irritation or rash occurs: Get medical advice/attention. If experiencing respiratory symptoms: Call a POISON CENTER or doctor/physician. Take off contaminated clothing and wash it before reuse. Dispose of contents/container in accordance with Local, State, Federal and Provincial regulations. Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye Contact with eyes may cause irritation. Signs/Symptoms Potential adverse reactions from prescribed doses and overdoses are described in the package insert. Side effects from therapeutic doses include: allergic reactions, hypotension, gastrointestinal neuromuscular, renal, and hepatic abnormalities. Occupational exposure has not been fully investigated. Aggravation of Pre-Existing Individuals with hypersensitivity to cefoxitin and to the cephalosporin and penicillin group of antibiotics. Conditions
